Brett K. Haumann, SVP Clin Development & Chief Med Ofc at Theravance Biopharma, Inc. (TBPH), sold 9,509 shares at $27.97 ($266K) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $266k TBPH by SVP Clin Development & Chief Med Ofc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2016-08-25 | $126K | — | Filing → |
| TBPH | SELL | 2016-08-25 | $126K | — | Filing → |
| TBPH | SELL | 2016-08-23 | $266K | — | Filing → |